Skip to main content
. 2021 Apr 29;11(5):1284. doi: 10.3390/ani11051284

Table 1.

Antimicrobials used in the study.

Microorganism A Category Antimicrobials B Category Antimicrobials
C. jejuni Quinolones (ciprofloxacin, CIP; nalidixic acid, NAL)
E. coli Glycylcyclines (tigecycline, TIG)
Carbapenems (meropenem, MER)
Cephalosporins (cefotaxime, CTA; ceftazidime, CTZ)
Polymyxins (colistin, COL)
Quinolones (ciprofloxacin, CIP; nalidixic acid, NAL)
E. faecalis Glycylcyclines (tigecycline, TIG)
Glycopeptides (vancomycin, VAN, teicoplanin, TEI)
Lipopeptides (daptomycin, DAP)
Oxazolidinones (linezolid, LIN) Streptogramins (Quinupristin-dalfopristin, QUD)
Quinolones (ciprofloxacin, CIP)